Android Apple

Concord Medical Services ADRs Climb After Chinese Hospital Unit Gets New License

By MarketWatch   |   3 months ago
Concord Medical Services ADRs Climb After Chinese Hospital Unit Gets New License

Concord Medical Services' stock surged 11% to $5.61 after its subsidiary received a major medical equipment license in China. The company, focused on cancer care and research, will soon offer proton therapy treatment at Guangzhou Concord Cancer Center.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.